Help pass the Lymphedema Treatment Act

View this email in your browser ([link removed]) Subscribe to Breast Cancer Action's email list ([link removed])
[link removed]
Hi
John,
For many people, breast cancer treatment comes with harsh, disabling side effects.

Lymphedema is a condition that causes incredibly painful swelling in the arms or legs due to the blocked flow of fluids. It is estimated that two of every five women treated for breast cancer develop lymphedema within five years of surgery.

Take Action and join us in calling on members of Congress to cosponsor the Lymphedema Treatment Act. ([link removed])
[link removed]
Patients need compression supplies to control this swelling—but Medicare and some private insurance companies don’t cover the costs of these supplies, leaving patients who can’t afford them to suffer from this debilitating condition.

This is unjust and inhumane.

The Lymphedema Treatment Act is an important piece of legislation that will change Medicare law to cover doctor-prescribed compression supplies—setting a precedent for Medicaid and other insurers to do the same. Now is the time to ask your Congress members to co-sponsor this important legislation that will get patients the supplies they need.

Tell Congress that people living with breast cancer deserve access to comprehensive treatment options, including the lymphedema compression supplies they need to heal and thrive. ([link removed])

In power,
Tibby Reas Hinderlie
Communications Manager
Donate Today ([link removed])

============================================================
** Twitter ([link removed])
** Facebook ([link removed])
** Instagram ([link removed])
** Website (www.bcaction.org)
** YouTube ([link removed])
** Email (mailto:[email protected])
Copyright ©2019 Breast Cancer Action, All rights reserved.

Our mailing address is:
548 Market St
PMB 17179
San Francisco, California 94104-5401

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.